Cargando…

Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer

BACKGROUND: Occult peritoneal metastasis (PM) in advanced gastric cancer (AGC) patients is highly possible to be missed on computed tomography (CT) images. Patients with occult PMs are subject to late detection or even improper surgical treatment. We therefore aimed to develop a radiomic nomogram to...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, D, Tang, L, Li, Z -Y, Fang, M -J, Gao, J -B, Shan, X -H, Ying, X -J, Sun, Y -S, Fu, J, Wang, X -X, Li, L -M, Li, Z -H, Zhang, D -F, Zhang, Y, Li, Z -M, Shan, F, Bu, Z -D, Tian, J, Ji, J -F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442651/
https://www.ncbi.nlm.nih.gov/pubmed/30689702
http://dx.doi.org/10.1093/annonc/mdz001
_version_ 1783407739087618048
author Dong, D
Tang, L
Li, Z -Y
Fang, M -J
Gao, J -B
Shan, X -H
Ying, X -J
Sun, Y -S
Fu, J
Wang, X -X
Li, L -M
Li, Z -H
Zhang, D -F
Zhang, Y
Li, Z -M
Shan, F
Bu, Z -D
Tian, J
Ji, J -F
author_facet Dong, D
Tang, L
Li, Z -Y
Fang, M -J
Gao, J -B
Shan, X -H
Ying, X -J
Sun, Y -S
Fu, J
Wang, X -X
Li, L -M
Li, Z -H
Zhang, D -F
Zhang, Y
Li, Z -M
Shan, F
Bu, Z -D
Tian, J
Ji, J -F
author_sort Dong, D
collection PubMed
description BACKGROUND: Occult peritoneal metastasis (PM) in advanced gastric cancer (AGC) patients is highly possible to be missed on computed tomography (CT) images. Patients with occult PMs are subject to late detection or even improper surgical treatment. We therefore aimed to develop a radiomic nomogram to preoperatively identify occult PMs in AGC patients. PATIENTS AND METHODS: A total of 554 AGC patients from 4 centers were divided into 1 training, 1 internal validation, and 2 external validation cohorts. All patients’ PM status was firstly diagnosed as negative by CT, but later confirmed by laparoscopy (PM-positive n = 122, PM-negative n = 432). Radiomic signatures reflecting phenotypes of the primary tumor (RS1) and peritoneum region (RS2) were built as predictors of PM from 266 quantitative image features. Individualized nomograms of PM status incorporating RS1, RS2, or clinical factors were developed and evaluated regarding prediction ability. RESULTS: RS1, RS2, and Lauren type were significant predictors of occult PM (all P < 0.05). A nomogram of these three factors demonstrated better diagnostic accuracy than the model with RS1, RS2, or clinical factors alone (all net reclassification improvement P < 0.05). The area under curve yielded was 0.958 [95% confidence interval (CI) 0.923–0.993], 0.941 (95% CI 0.904–0.977), 0.928 (95% CI 0.886–0.971), and 0.920 (95% CI 0.862–0.978) for the training, internal, and two external validation cohorts, respectively. Stratification analysis showed that this nomogram had potential generalization ability. CONCLUSION: CT phenotypes of both primary tumor and nearby peritoneum are significantly associated with occult PM status. A nomogram of these CT phenotypes and Lauren type has an excellent prediction ability of occult PM, and may have significant clinical implications on early detection of occult PM for AGC.
format Online
Article
Text
id pubmed-6442651
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-64426512019-04-04 Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer Dong, D Tang, L Li, Z -Y Fang, M -J Gao, J -B Shan, X -H Ying, X -J Sun, Y -S Fu, J Wang, X -X Li, L -M Li, Z -H Zhang, D -F Zhang, Y Li, Z -M Shan, F Bu, Z -D Tian, J Ji, J -F Ann Oncol Original Articles BACKGROUND: Occult peritoneal metastasis (PM) in advanced gastric cancer (AGC) patients is highly possible to be missed on computed tomography (CT) images. Patients with occult PMs are subject to late detection or even improper surgical treatment. We therefore aimed to develop a radiomic nomogram to preoperatively identify occult PMs in AGC patients. PATIENTS AND METHODS: A total of 554 AGC patients from 4 centers were divided into 1 training, 1 internal validation, and 2 external validation cohorts. All patients’ PM status was firstly diagnosed as negative by CT, but later confirmed by laparoscopy (PM-positive n = 122, PM-negative n = 432). Radiomic signatures reflecting phenotypes of the primary tumor (RS1) and peritoneum region (RS2) were built as predictors of PM from 266 quantitative image features. Individualized nomograms of PM status incorporating RS1, RS2, or clinical factors were developed and evaluated regarding prediction ability. RESULTS: RS1, RS2, and Lauren type were significant predictors of occult PM (all P < 0.05). A nomogram of these three factors demonstrated better diagnostic accuracy than the model with RS1, RS2, or clinical factors alone (all net reclassification improvement P < 0.05). The area under curve yielded was 0.958 [95% confidence interval (CI) 0.923–0.993], 0.941 (95% CI 0.904–0.977), 0.928 (95% CI 0.886–0.971), and 0.920 (95% CI 0.862–0.978) for the training, internal, and two external validation cohorts, respectively. Stratification analysis showed that this nomogram had potential generalization ability. CONCLUSION: CT phenotypes of both primary tumor and nearby peritoneum are significantly associated with occult PM status. A nomogram of these CT phenotypes and Lauren type has an excellent prediction ability of occult PM, and may have significant clinical implications on early detection of occult PM for AGC. Oxford University Press 2019-03 2019-01-23 /pmc/articles/PMC6442651/ /pubmed/30689702 http://dx.doi.org/10.1093/annonc/mdz001 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Dong, D
Tang, L
Li, Z -Y
Fang, M -J
Gao, J -B
Shan, X -H
Ying, X -J
Sun, Y -S
Fu, J
Wang, X -X
Li, L -M
Li, Z -H
Zhang, D -F
Zhang, Y
Li, Z -M
Shan, F
Bu, Z -D
Tian, J
Ji, J -F
Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer
title Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer
title_full Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer
title_fullStr Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer
title_full_unstemmed Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer
title_short Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer
title_sort development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442651/
https://www.ncbi.nlm.nih.gov/pubmed/30689702
http://dx.doi.org/10.1093/annonc/mdz001
work_keys_str_mv AT dongd developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT tangl developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT lizy developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT fangmj developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT gaojb developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT shanxh developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT yingxj developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT sunys developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT fuj developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT wangxx developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT lilm developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT lizh developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT zhangdf developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT zhangy developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT lizm developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT shanf developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT buzd developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT tianj developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer
AT jijf developmentandvalidationofanindividualizednomogramtoidentifyoccultperitonealmetastasisinpatientswithadvancedgastriccancer